Peripheral Stent Implants - Global Strategic Business Report

The global market for Peripheral Stent Implants was estimated at US$4.0 Billion in 2024 and is projected to reach US$5.6 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Peripheral Stent Implants market.

Global Peripheral Stent Implants Market - Key Trends & Drivers Summarized

Why Are Peripheral Stent Implants Critical in Restoring Blood Flow in Arterial Disease?

Peripheral stent implants are medical devices used to open narrowed or blocked arteries in the limbs, particularly in cases of peripheral artery disease (PAD). These stents provide structural support to keep vessels open, restore blood circulation, and prevent complications such as tissue ischemia or amputation. They are deployed via catheter-based procedures, offering a minimally invasive alternative to surgical bypass.

PAD is strongly associated with diabetes, smoking, and aging, making stenting a central intervention in vascular medicine. Stents are particularly important in treating femoropopliteal and iliac artery blockages, where traditional angioplasty may not offer long-term patency. Continued refinement in stent design and deployment techniques is improving durability and patient outcomes.

How Are Technologies Advancing for Improved Efficacy and Safety?

Stent innovation is focused on increasing radial strength, flexibility, and long-term patency while minimizing restenosis and fracture. Nitinol-based self-expanding stents are widely used for peripheral vessels due to their adaptability to movement and vessel compression. Drug-eluting stents (DES) and drug-coated stents (DCS) release antiproliferative agents like paclitaxel to reduce the risk of re-narrowing.

Bioabsorbable stents, though still under evaluation, offer the potential for temporary scaffolding with reduced long-term complications. Improved stent delivery systems, low-profile catheters, and imaging-assisted placement tools are enhancing procedural precision. Additionally, new stents designed specifically for challenging anatomies such as below-the-knee (BTK) arteries are supporting expanded treatment indications.

Where Is Market Growth Concentrated and Which Conditions Are Driving Adoption?

Adoption is highest in vascular surgery centers, catheterization labs, and interventional radiology units across developed healthcare systems. North America and Europe lead in procedural volume due to well-established PAD screening and interventional infrastructure. Asia-Pacific is witnessing rapid growth in stent procedures driven by aging populations, increased prevalence of diabetes, and improving access to vascular care.

The primary drivers of stent implantation include intermittent claudication, critical limb ischemia, and chronic total occlusions. Device adoption is expanding in outpatient and ambulatory surgical centers as stenting procedures become more streamlined and less resource-intensive. Early-stage PAD management strategies are also incorporating stents to improve functional outcomes and prevent progression to severe limb ischemia.

Growth in the Peripheral Stent Implants market is driven by several factors

Growth in the peripheral stent implants market is driven by factors such as rising incidence of peripheral artery disease, advancements in stent material and design, and growing preference for minimally invasive vascular interventions. Expanding clinical use of drug-eluting and self-expanding stents is improving long-term outcomes and supporting broader procedural adoption.

Improvements in stent visibility, flexibility, and compatibility with vessel dynamics are enhancing procedural safety. Increasing investments in outpatient endovascular procedures, supportive reimbursement policies, and training of interventional specialists are further fueling market expansion. As population aging and vascular risk factors continue to rise, peripheral stenting remains a cornerstone of PAD treatment strategies worldwide.

Scope Of Study:

The report analyzes the Peripheral Stent Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Product (Bare Metal Stents, Covered Stents, Drug Eluting Stents); End-Use (Hospitals End-Use, Ambulatory Surgery Centers / Outpatient End-Use); Artery (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, Infrapop Artery Stents)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Bare Metal Stents segment, which is expected to reach US$3.3 Billion by 2030 with a CAGR of a 6.8%. The Covered Stents segment is also set to grow at 5.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $1.1 Billion in 2024, and China, forecasted to grow at an impressive 9.6% CAGR to reach $1.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Peripheral Stent Implants Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Peripheral Stent Implants Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Peripheral Stent Implants Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott, Admedes GmbH, Alvimedica, B. Braun Melsungen AG, Bentley InnoMed GmbH and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 36 companies featured in this Peripheral Stent Implants market report include:

• Abbott
• Admedes GmbH
• Alvimedica
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biotronik
• Boston Scientific
• Cardinal Health
• Cook Medical
• Cordis
• Endologix LLC
• Gore Medical (W. L. Gore)
• iVascular
• JOTEC GmbH (CryoLife)
• Medinol
• Medtronic
• MicroPort Scientific
• SMT (Sahajanand Medical Tech)
• Terumo Corporation
• Translumina Therapeutics

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.